Emerging therapies against infections with Pseudomonas aeruginosa [version 1; peer review: 2 approved]
Infections with Pseudomonas aeruginosa have been marked with the highest priority for surveillance and epidemiological research on the basis of parameters such as incidence, case fatality rates, chronicity of illness, available options for prevention and treatment, health-care utilization, and socie...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2019-08-01
|
| Series: | F1000Research |
| Online Access: | https://f1000research.com/articles/8-1371/v1 |